ArticleMolecular biology reports2026
Transcriptome remodeling of mouse hearts during postnatal cardiac maturation and under proteotoxic stress.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDesmin-related cardiomyopathy (DRC) is a proteotoxic disorder driven by mutations in DES and related genes such as CRYABR120G (R120G), leading to progressive cardiac dysfunction. While late-stage transcriptomic changes in cardiomyopathy and aging are well studied, early molecular events during postnatal maturation and disease onset remain poorly defined. METHODS AND
resultsThrough RNA sequencing of mouse ventricular myocardium at multiple time points, we uncovered novel transcriptional changes associated with postnatal cardiac development in non-transgenic mice, as well as early alterations preceding overt pathology in the R120G-based DRC mice. RT-qPCR and western blotting confirmed the kinase SBK2 was downregulated in multiple DRC mouse models, suggesting a conserved role in disease progression. Comparative analysis of our sequencing datasets and an independent RNA-seq dataset, identified a conserved molecular signature involving autophagy and proteasome pathways, notably including the proteasome subunit Psmd5. Profiler enrichment analysis uncovered shared transcription factor binding motifs implicating a previously unrecognized transcriptional regulator in disease progression.
conclusionsThese findings identify Sbk2, Psmd5, Scml4, Snai3, and Foxn4 as novel candidates in DRC pathogenesis. In the non-transgenic heart, data implicate several transcriptional networks governing the shift from cardiac maturation to detrimental aging including AW551984 and a group of zinc finger C2H2 transcription factors (Zfp41, Zfp273, Zfp456, Zfp469, and Zfp820). These genes have not been studied in the context of cardiac maturation hinting at an unexplored cardiac regulatory network. These findings may provide novel mechanistic insights into the transition from postnatal cardiac maturation to detrimental cardiac aging and proteotoxic stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.